ReviewFrontiers in pharmacology2025
Anticancer potential of natural bioactive compounds saponins in glioblastoma multiforme.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
According to the WHO Organization, glioblastoma multiforme (GM) is classified as a grade IV histological malignant tumor of the central nervous system. Numerous genetic abnormalities (tumor cells) and dysregulated cell cycle checkpoints, such as G1/S, have been linked to the progression of glioblastoma multiforme. In addition to tumor removal, glioblastoma multiforme can be treated with chemotherapy and radiotherapy. Immunotherapy and medications that block integrin signaling pathways have also been used. Owing to tumor recurrence, metastasis, and treatment resistance, conventional pharmacological regimens continue to be lethal. Consequently, the quest for an efficacious therapeutic approach for GM remains elusive. Innovative products derived from natural substances have also been proposed as potential remedies. They safeguard glial cells by inducing apoptosis, reducing oxidative stress and neuroinflammation, suppressing proliferation, decreasing pro-oncogenic processes, and enhancing the effectiveness of anticancer therapies. Among various natural compounds, saponins are now being considered for use in cancer treatment. The function and mechanism of action of saponins in cancer have been reported in numerous research findings. These anticancer effects include antioxidant activity, apoptotic induction, cell cycle arrest, and suppression of cellular invasion and migration. This review presents the application of natural saponins as a potential alternative for developing a novel therapeutic strategy that will enhance the treatment options for combating GM in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.